J. Herman

Molecular Biology · Nature · 2000–2016

A researcher in the Science corpus: 25 papers; trusts 3 researchers and is trusted by 9 researchers here, as inferred from the citation graph.

Subfields

Molecular Biology — 254 citations into it; #3,165 of 17,773 by trust here, #294 by citations
Genetics — 129 citations into it; #2,355 of 6,854 by trust here, #191 by citations

Whom J. Herman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts J. Herman overall

Papers from J. Herman's perspective

Ordered by how strongly the researchers J. Herman trusts endorse each paper. Same corpus, a different order for every researcher.

DNA hypermethylation in tumorigenesis: epigenetics joins genetics. (Trends in Genetics)
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. (Cell)
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells (Nature)
Control of developmental regulators by Polycomb in human embryonic stem cells. (Cell)
CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus (Nature)
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci (Nature Genetics)
Predicting lung cancer by detecting aberrant promoter methylation in sputum. (Cancer Research)
Early detection: The power and the promise of DNA methylation markers (Nature Reviews. Cancer)
Anticancer activities of histone deacetylase inhibitors (Nature reviews. Drug discovery)
Chromatin signatures of pluripotent cell lines (Nature Cell Biology)

Their papers

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. (2010) — 2,267 citations
DNA hypermethylation in tumorigenesis: epigenetics joins genetics. (2000) — 1,699 citations
A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing (2007) — 1,146 citations
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (2001) — 1,008 citations
Gene silencing in cancer in association with promoter hypermethylation. (2003) — 3,472 citations
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer (2002) — 888 citations
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours (2002) — 801 citations
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas (2016) — 1,096 citations
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer (2004) — 1,111 citations
Integrated Genomic Analyses of Ovarian Carcinoma (2011) — 7,559 citations
Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) — 7,050 citations
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. (2000) — 1,255 citations
Comprehensive molecular profiling of lung adenocarcinoma (2014) — 5,176 citations
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. (2008) — 818 citations
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non Small Cell Lung Cancer (2011) — 619 citations
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. (2001) — 970 citations
Genomic Classification of Cutaneous Melanoma (2015) — 2,764 citations
Integrated Genomic Characterization of Papillary Thyroid Carcinoma (2014) — 2,692 citations
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity (2001) — 742 citations
Comprehensive genomic characterization of head and neck squamous cell carcinomas (2015) — 3,702 citations